Table 7.
Treatment-related outcomes most important to patients with or at risk for AD and care partners
| Ideal treatment outcome, n (%) | AD classification | Total (N = 60) | ||||
|---|---|---|---|---|---|---|
| Group 1 (n = 12) | Group 2 (n = 12) | Group 3 (n = 12) | Group 4 (n = 12) | Group 5 (n = 12) | ||
| Improve/restore memory | 9 (75.0) | 7 (58.3) | 5 (41.7) | 9 (75.0) | 10 (83.3) | 40 (66.7) |
| Stop AD progression | 8 (66.7) | 6 (50.0) | 7 (58.3) | 7 (58.3) | 7 (58.3) | 35 (58.3) |
| Slow AD progression | 4 (33.3) | 6 (50.0) | 3 (25.0) | 5 (41.7) | 2 (16.7) | 20 (33.3) |
| Improve ability to function, perform ADLs | 4 (33.3) | 0 (0.0) | 1 (8.3) | 5 (41.7) | 5 (41.7) | 15 (25.0) |
| Improve short-term memory | 3 (25.0) | 3 (25.0) | 3 (25.0) | 3 (25.0) | 2 (16.7) | 14 (23.3) |
| Remember family | 5 (41.7) | 0 (0.0) | 2 (16.7) | 3 (25.0) | 2 (16.7) | 12 (20.0) |
| Cure AD | 1 (8.3) | 3 (25.0) | 1 (8.3) | 3 (25.0) | 3 (25.0) | 11 (18.3) |
| Help remain independent, not be a burden | 1 (8.3) | 0 (0.0) | 0 (0.0) | 2 (16.7) | 3 (25.0) | 6 (10.0) |
| Remove plaque/tangles/stop growth | 2 (16.7) | 0 (0.0) | 1 (8.3) | 0 (0.0) | 3 (25.0) | 6 (10.0) |
| Be sharper, more focused | 0 (0.0) | 3 (25.0) | 0 (0.0) | 1 (8.3) | 1 (8.3) | 5 (8.3) |
| Be aware of self and surroundings | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (8.3) | 3 (25.0) | 4 (6.7) |
| Improve long-term memory | 1 (8.3) | 0 (0.0) | 0 (0.0) | 2 (16.7) | 0 (0.0) | 3 (5.0) |
| Stop hallucinations | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (8.3) | 0 (0.0) | 1 (1.7) |
AD Alzheimer’s disease, ADLs activities of daily living
Note: Participants were allowed to report multiple treatment outcomes; thus, the sums exceed 100%. Data shown are the number and percentage of individuals endorsing an outcome in each group and overall. Information was collected from patients only from groups 1, 2, and 3; from care partners and patients (when able to self-report) in group 4; and from care partners only in group 5